Long intergenic non-protein coding RNA 868 (LINC00868)

Long intergenic non-protein coding RNA 868 (LINC00868) is a non-protein-coding RNA gene classified as a long intergenic non-coding RNA (lincRNA), meaning its transcripts do not overlap with protein-coding genes and are typically over 200 nucleotides in length[1][5][3][7]. lincRNAs constitute a substantial subset of long non-coding RNAs and are involved in diverse regulatory functions, including chromatin remodeling, modulation of genome architecture, RNA stabilization, regulation of transcription (sometimes through enhancer-like mechanisms), and fine-tuning the expression of neighboring or distal genes[3][7]. While the general class of lincRNAs has clear roles in gene regulation and disease, and individual lincRNAs have been implicated in cancer and other diseases, there is currently limited or no evidence suggesting that LINC00868 itself is a validated therapeutic target such as a receptor, enzyme, transporter, or transcription factor[1][5]. It is annotated and studied primarily as a functional non-coding RNA gene, with other aliases including C17orf52[1][5]. There are no known drugs, biomarkers, or safety concerns specifically associated with this molecule at present[1][5].

Other names

C17orf52LINC00868